 SEATTLE and VANCOUVER, BC, Oct. 29, 2020 PRNewswire -- Achieve Life Sciences, Inc. Nasdaq: ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it... 